Patents by Inventor Rajesh A. Patel

Rajesh A. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150302388
    Abstract: A computer-implemented method that requires an inventive special-purpose software apparatus is disclosed. The apparatus comprises software subsystems that facilitate Patrons using a Mobile Application, to easily find and then submit gratuity payments to Service Providers.
    Type: Application
    Filed: April 15, 2015
    Publication date: October 22, 2015
    Applicant: Gratzeez, LLC
    Inventors: Glenn Robert Seidman, Denise Anne Holt, Rajesh A Patel, Ragin Thakorbhai Desai
  • Publication number: 20150151029
    Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
    Type: Application
    Filed: October 3, 2014
    Publication date: June 4, 2015
    Inventors: Rajesh A. PATEL, Louis R. BUCALO, Lauren COSTANTINI, Sofie KLEPPNER
  • Publication number: 20140343282
    Abstract: Novel synthetic approaches to make 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide, intermediates and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: May 16, 2014
    Publication date: November 20, 2014
    Applicant: Apicore, LLC
    Inventors: Ravishanker Kovi, Jayaraman Kannapan, Sanjay F. Thakor, Rajesh A Patel
  • Patent number: 8852623
    Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: October 7, 2014
    Assignee: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo, Lauren Costantini, Sofie Kleppner
  • Publication number: 20140171457
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Application
    Filed: November 26, 2013
    Publication date: June 19, 2014
    Applicant: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Publication number: 20140161860
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Application
    Filed: November 26, 2013
    Publication date: June 12, 2014
    Applicant: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Publication number: 20140163057
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Application
    Filed: November 26, 2013
    Publication date: June 12, 2014
    Applicant: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Publication number: 20140088131
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Application
    Filed: November 26, 2013
    Publication date: March 27, 2014
    Applicant: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Publication number: 20130189342
    Abstract: The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.
    Type: Application
    Filed: March 16, 2011
    Publication date: July 25, 2013
    Applicant: TITAN PHARMACEUTICALS, INC.
    Inventors: Rajesh A. Patel, Sunil R. Bhonsle
  • Publication number: 20120258161
    Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 11, 2012
    Inventors: Rajesh A. PATEL, Louis R. Bucalo, Lauren Costantini, Sofie Kleppner
  • Patent number: 7736665
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: June 15, 2010
    Assignee: Titan Pharmaceuticals, Inc.
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Publication number: 20090162412
    Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 25, 2009
    Inventors: Rajesh A. Patel, Louis R. Bucalo, Lauren Costantini, Sofie Kleppner
  • Publication number: 20080311171
    Abstract: The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist.
    Type: Application
    Filed: May 12, 2008
    Publication date: December 18, 2008
    Inventors: Rajesh A. PATEL, Louis R. Bucalo, Lauren Costantini, Sofie Kleppner
  • Publication number: 20040033250
    Abstract: The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
    Type: Application
    Filed: June 2, 2003
    Publication date: February 19, 2004
    Inventors: Rajesh A. Patel, Louis R. Bucalo
  • Patent number: 5977171
    Abstract: Ophthalmic methods and compositions are disclosed where particles of the dispersed phase of emulsions are themselves dispersed and stably maintained in physical separation by lightly crosslinked, water swellable polymers present in an aqueous polymeric system formulated for administration to the eye in drop or ribbon form. Medicament is dissolved in that dispersed phase is delivered over a sustained release period.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: November 2, 1999
    Assignee: InSite Vision, Inc.
    Inventors: Lyle M. Bowman, Rajesh A. Patel, Thomas B. Ottoboni
  • Patent number: 5767153
    Abstract: Ophthalmic methods and compositions are disclosed where particles of the dispersed phase of emulsions are themselves dispersed and stably maintained in physical separation by lightly crosslinked, water swellable polymers present in an aqueous polymeric system formulated for administration to the eye in drop or ribbon form. Medicament is dissolved in that dispersed phase is delivered over a sustained release period.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 16, 1998
    Assignee: Insite Vision Incorporated
    Inventors: Lyle M. Bowman, Rajesh A. Patel, Thomas B. Ottoboni
  • Patent number: 5458890
    Abstract: Flavored food and pharmaceutical compositions include one or more flavor additives incorporated within polymeric particles, usually within an internal pore network defined by individual polymeric particles. The polymeric particles are, in turn, dispersed within and/or over a surface of an orally-deliverable matrix material, which is usually a solid or semi-solid substrate. In the case of chewable compositions, the flavor additives will be released into the orally-deliverable matrix material as the composition is chewed and held in the mouth, thus prolonging the flavor of the composition. In the case of dried powders and mixes, the flavor will typically be made available as the product is consumed or be released into the matrix material as the composition is further processed. When two flavors are combined with the polymeric particles, the relative amounts of the additives can be selected to provide simultaneous release and exhaustion of the additives.
    Type: Grant
    Filed: June 4, 1991
    Date of Patent: October 17, 1995
    Assignee: Advanced Polymer Systems, Inc.
    Inventors: John H. Williford, Martin Katz, Sergio Nacht, Chung-Heng Cheng, Rajesh A. Patel, Brian J. Picard